CD36 and ovarian carcinoma: CAAs directly contribute to ovarian cancer progression mostly via increased lipolysis and produce more FAs, which are further transferred to ovarian cancer cells and enter through CD36, FATPs, and FABPs, providing energy for rapid cellular division and metastasis of ovarian cancer cells through enhanced FAO.